Please assess the completion status of the following clinical trial:

Trial Title: A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with at least 2 documented episodes of paroxysmal Atrial Fibrillation (AF) which are not responders to at least one antiarrythmic drug~Exclusion Criteria:~* Previous left atrial ablation procedure or surgery~* left atrium diameter \> 50mm~* presence of intracardiac thrombus~* Left ventricular ejection fraction \< 40%~* Heart failure class III-IV~* Severe valvulopathies~* Acute coronary syndrome or cardiac surgery within the previous 3 months of enrollment~* Transient ischemic attack/stroke within the previous 6 months of enrollment~* life expectancy less than 1 year~* Any contraindication to the procedure according to the current clinical practice

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Control Arm (Type: ACTIVE_COMPARATOR): Conventional protocol for cryoablation:~At least 2 applications of 180s each
- Study Arm (Type: EXPERIMENTAL): Experimental protocol for cryoablation:~Time to effect + 1 minute and a bonus application of 120s

Based on this trial design, predict the completion outcome and termination type (if applicable).